NCT02178644View on ClinicalTrials.gov

Pilot Trial of KD018 With Neo-Adjuvant Concurrent Chemo-Radiation Therapy in Patients With Locally Advanced Rectal Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

September 20, 2019

Study Completion Date

September 20, 2019

Conditions
Rectal Cancer
Interventions
DRUG

Chemo with concomitant Capecitabine and KD018

Patients will receive a course of chemo-radiation with concomitant Capecitabine and KD018, and to compare this to the toxicity seen in patients treated with Capecitabine and radiation therapy alone, in patients with T3-T4 and N0-N2, M0 rectal cancer.

Trial Locations (1)

06519

Yale Cancer Center, New Haven

All Listed Sponsors
lead

Yale University

OTHER

NCT02178644 - Pilot Trial of KD018 With Neo-Adjuvant Concurrent Chemo-Radiation Therapy in Patients With Locally Advanced Rectal Cancer | Biotech Hunter | Biotech Hunter